Structures by: Ellena J.
Total: 217
4-BENZYL-5-ETHYLTHIO-3H-1,2-DITHIOLE-3-THIONE
C12H12S4
Acta Crystallographica Section C (1997) 53, 8 1125-1127
a=9.5433(5)Å b=11.0572(7)Å c=13.0444(5)Å
α=78.840(4)° β=89.737(4)° γ=89.700(4)°
2-methyl-5-nitroaniline
C7H8N2O2
Acta Crystallographica, Section B: Structural Science (1999) 55, 2 209-215
a=9.369(2)Å b=5.5630(10)Å c=13.626(3)Å
α=90.00° β=92.36(3)° γ=90.00°
2-Nitro-4-methylaniline
C7H8N2O2
Acta Crystallographica Section C (1996) 52, 8 2074-2076
a=13.401(4)Å b=9.103(2)Å c=12.375(8)Å
α=90° β=103.84(3)° γ=90°
2,4-Dinitro-N,N-methylphenylamine
C13H11N3O4
Acta Crystallographica Section C (1997) 53, 12 1930-1932
a=7.027(4)Å b=12.436(3)Å c=14.390(4)Å
α=90.00° β=93.95(4)° γ=90.00°
2,4-Dinitro-diphenyl-sulfone
C12H8N2O6S
Acta Crystallographica Section C (1996) 52, 11 2929-2932
a=10.661(2)Å b=5.478(2)Å c=11.383(3)Å
α=90.00° β=104.57(2)° γ=90.00°
1-(<i>o</i>-Tolyl)thiourea
C8H10N2S
Acta Crystallographica Section E (2008) 64, 9 o1670-o1671
a=15.1323(3)Å b=7.7965(2)Å c=15.3222(4)Å
α=90° β=90.828(2)° γ=90°
7-Amino-1-(3-bromophenyl)-3-cyanopyrazolo[4,3-d]pyrimidine
C12H7BrN6
Acta Crystallographica Section E (2006) 62, 11 o5246-o5248
a=7.7153(3)Å b=7.6270(4)Å c=20.3497(7)Å
α=90° β=95.560(2)° γ=90°
Nevirapine butanol 0.3-solvate
C15H14N4O,0.3C4H10O
Acta Crystallographica Section E (2008) 64, 1 o292-o292
a=7.8116(6)Å b=8.4302(7)Å c=12.5451(11)Å
α=84.817(5)° β=88.415(5)° γ=68.252(4)°
1-(2-Furoyl)-3-(<i>o</i>-tolyl)thiourea
C13H12N2O2S
Acta Crystallographica Section E (2008) 64, 8 o1414
a=6.09760(10)Å b=16.6689(6)Å c=13.1462(4)Å
α=90° β=108.765(2)° γ=90°
<i>N</i>-(3-Chlorophenyl)maleimide
C10H6ClNO2
Acta Crystallographica Section E (2008) 64, 5 o932
a=7.3434(3)Å b=11.9458(5)Å c=10.3044(4)Å
α=90.00° β=101.121(2)° γ=90.00°
<i>N</i>-(4-Chlorophenyl)maleimide
C10H6ClNO2
Acta Crystallographica Section E (2008) 64, 10 o1991
a=10.6504(7)Å b=3.8589(2)Å c=22.0308(14)Å
α=90.00° β=100.741(3)° γ=90.00°
1-Furfuryl-3-furoylthiourea
C11H10N2O3S
Acta Crystallographica Section E (2008) 64, 6 o1157
a=4.5999(2)Å b=11.3792(6)Å c=12.0556(5)Å
α=68.351(3)° β=83.187(4)° γ=89.367(3)°
8-Hydroxy-5,6,7-trimethoxy-2-phenyl-4H-chromen-4-one
C18H16O6
Acta Crystallographica Section E (2008) 64, 5 o899
a=8.4536(2)Å b=9.0878(2)Å c=10.7832(3)Å
α=79.545(2)° β=71.5640(10)° γ=86.925(2)°
1-(3-Cyanophenyl)-3-(2-furoyl)thiourea
C13H9N3O2S
Acta Crystallographica Section E (2008) 64, 7 o1193
a=16.7375(5)Å b=3.87890(10)Å c=19.6739(5)Å
α=90° β=96.9560(10)° γ=90°
2-Benzoylpyridine semicarbazone
C13H12N4O
Acta Crystallographica Section E (2008) 64, 1 o177-o177
a=22.9281(7)Å b=9.1868(2)Å c=23.1869(7)Å
α=90° β=93.0490(10)° γ=90°
N-(2-Furylcarbonyl)piperidine-1-carbothioamide
C11H14N2O2S1
Acta Crystallographica Section E (2008) 64, 8 o1457
a=31.6377(15)Å b=8.6787(4)Å c=8.5308(3)Å
α=90° β=90° γ=90°
Methyl-p-aminobenzoate
C8H9NO2
Acta Crystallographica Section C (2004) 60, 1 o69-o71
a=8.5969(4)Å b=5.6053(2)Å c=15.5397(7)Å
α=90° β=96.172(2)° γ=90°
Caesium lithium sulfate
Cs1.15Li2.85(SO4)2
Acta Crystallographica Section C (2003) 59, 7 i67-i70
a=5.0620(2)Å b=5.2230(3)Å c=16.0060(9)Å
α=90.00° β=90.00° γ=90.00°
Caesium lithium rubidium sulfate
Cs0.90Li2.88Rb0.22(SO4)2
Acta Crystallographica Section C (2003) 59, 7 i67-i70
a=5.0530(2)Å b=5.1990(4)Å c=15.9840(8)Å
α=90.00° β=90.297(3)° γ=90.00°
2-(2-oxothiazolidin-3-yl)-4,5-dihydrothiazolium hydrogen sulfate monohydrate
C6H9N2OS2,HO4S,H2O
Acta Crystallographica Section C (2008) 64, 7 o395-o397
a=5.8508(2)Å b=13.0999(4)Å c=15.4187(5)Å
α=90° β=90° γ=90°
4-(2,5-dioxo-2,5-dihydro-1<i>H</i>-pyrrol-1-yl)benzoic acid
C11H7NO4
Acta Crystallographica Section C (2011) 67, 2 o67-o70
a=7.3326(5)Å b=9.8832(5)Å c=13.3922(11)Å
α=90.00° β=90.00° γ=90.00°
Poly[μ~2~-aqua-m~3~-dimethylformide-bis(μ~3~-phenylphosphonato)dipotassium]
C15H21K2NO8P2
Acta Crystallographica Section C (2005) 61, 4 m161-m164
a=16.988(5)Å b=8.264(5)Å c=16.684(5)Å
α=90° β=115.545(5)° γ=90°
Mammeigin
C25H24O5
Acta Crystallographica Section C (2006) 62, 6 o350-o352
a=16.7270(10)Å b=14.1520(10)Å c=8.7180(10)Å
α=90° β=90.790(10)° γ=90°
3-Nitrophenol--4,4'-bipyridyl <i>N</i>,<i>N</i>'-dioxide (2/1)
2(C6H5NO3),C10H8N2O2
Acta Crystallographica Section C (2010) 66, 8 o425-o428
a=10.5167(14)Å b=5.9729(13)Å c=18.2602(10)Å
α=90.00° β=105.700(7)° γ=90.00°
Lupeol
C30H50O
Acta Crystallographica Section C (2009) 65, 3 o97-o99
a=19.1006(14)Å b=19.1006(14)Å c=7.2128(4)Å
α=90° β=90° γ=90°
Pd_iii
C36H30Cl2P2Pd1
Acta Crystallographica Section C (2011) 67, 9 m304-m306
a=9.9830(3)Å b=11.3023(3)Å c=15.6037(5)Å
α=89.947(2)° β=89.5390(10)° γ=63.9260(10)°
4-{2-[4-(Dimethylamino)phenyl]ethylidene}benzonitrile
C17H16N2
Acta Crystallographica Section E (2009) 65, 6 o1371
a=6.2009(2)Å b=7.9706(3)Å c=27.9619(11)Å
α=90.00° β=93.6027(13)° γ=90.00°
Bis(tetraphenylphosphonium) tris[<i>N</i>-(methylsulfonyl)dithiocarbimato(2-)- κ^2^<i>S</i>,<i>S</i>]stannate(IV)
2(C24H20P),C6H9N3O6S9Sn2
Acta Crystallographica Section E (2009) 65, 10 m1154-m1155
a=18.5563(3)Å b=13.6096(2)Å c=23.3203(3)Å
α=90° β=91.3550(10)° γ=90°
1-benzyl-3-furoyl-1-phenylthiourea
C19H16N2O2S
Acta Crystallographica Section E (2009) 65, 3 o648
a=12.7737(3)Å b=8.8047(2)Å c=31.2345(7)Å
α=90° β=90° γ=90°
2-[(2-Carboxyphenyl)disulfanyl]benzoic acid--4,4'-bipyridyl <i>N</i>,<i>N</i>'-dioxide (1/2)
2(C14H10O4S2),C10H8N2O2
Acta Crystallographica Section E (2010) 66, 6 o1442
a=21.314(2)Å b=10.5621(8)Å c=16.005(8)Å
α=90.00° β=105.412(8)° γ=90.00°
<i>cis</i>-Bis{1,1-dibenzyl-3-[(furan-2-yl)carbonyl]thioureato- κ^2^<i>O</i>,<i>S</i>}nickel(II)
C40H34N4NiO4S2
Acta Crystallographica Section E (2011) 67, 4 m504
a=18.7260(4)Å b=10.8430(2)Å c=19.6490(5)Å
α=90° β=114.6280(10)° γ=90°
2-(Phenylcarbonothioylsulfanyl)acetic acid
C9H8O2S2
Acta Crystallographica Section E (2010) 66, 10 o2614
a=13.1565(7)Å b=4.9522(2)Å c=17.3747(7)Å
α=90.00° β=121.870(3)° γ=90.00°
1-Furoyl-3-[3-(trifluoromethyl)phenyl]thiourea
C13H9F3N2O2S1
Acta Crystallographica Section E (2009) 65, 5 o1012
a=7.5540(14)Å b=13.684(5)Å c=14.210(3)Å
α=86.124(13)° β=74.779(7)° γ=74.065(8)°
3-Nitrobenzoic acid--3-methyl-4-nitropyridine 1-oxide (1/1)
C7H5NO4,C6H6N2O3
Acta Crystallographica Section E (2009) 65, 7 o1680-o1681
a=7.1221(4)Å b=11.0660(2)Å c=17.9921(4)Å
α=90.00° β=98.170(4)° γ=90.00°
Imidazolium fumarate
C3H5N2,C4H3O4
Acta Crystallographica Section E (2009) 65, 11 o2717
a=7.4794(4)Å b=7.7522(3)Å c=8.4231(4)Å
α=69.695(3)° β=81.415(2)° γ=66.193(2)°
<i>cis</i>-Bis[1,1-dibenzyl-3-(furan-2-ylcarbonyl)thioureato- κ^2^<i>O</i>,<i>S</i>]copper(II)
C40H34CuN4O4S2
Acta Crystallographica Section E (2011) 67, 5 m621
a=18.8390(3)Å b=10.8730(2)Å c=19.6200(3)Å
α=90° β=114.7480(10)° γ=90°
4-Methylphenyl 4-bromobenzoate
C14H11BrO2
Acta Crystallographica Section E (2011) 67, 11 o2869
a=15.0219(9)Å b=11.3585(8)Å c=7.5077(4)Å
α=90.00° β=99.730(4)° γ=90.00°
4-[(2-Carboxyphenyl)sulfanyl]pyridine <i>N</i>-oxide
C12H9NO3S
Acta Crystallographica Section E (2014) 70, 6 o644
a=8.9894(8)Å b=5.7373(3)Å c=22.5855(18)Å
α=90.00° β=111.348(4)° γ=90.00°
2,4,6-Trinitrophenyl 3-bromobenzoate
C13H6BrN3O8
Acta Crystallographica Section E (2014) 70, 6 o689
a=11.2925(4)Å b=9.5672(3)Å c=14.0560(6)Å
α=90.00° β=94.625(2)° γ=90.00°
9-(4-bromobutyl)-9<i>H</i>-carbazole
C16H16BrN
Acta Crystallographica Section E (2012) 68, 6 o1853
a=16.0949(4)Å b=7.7012(2)Å c=22.6874(4)Å
α=90.00° β=90.00° γ=90.00°
6-Bromopyridine-2-carbaldehyde phenylhydrazone
C12H10BrN3
Acta Crystallographica Section E (2012) 68, 7 o2131
a=14.6418(3)Å b=7.84070(10)Å c=20.0645(4)Å
α=90.00° β=90.00° γ=90.00°
2,2'-(1,4-Phenylene)bis(propane-2,2-diyl) bis(benzodithioate)
C26H26S4
Acta Crystallographica Section E (2014) 70, 2 o117
a=8.6981(6)Å b=11.7074(7)Å c=12.5612(6)Å
α=90.00° β=107.626(4)° γ=90.00°
<i>cis</i>-Bis(1,10-phenanthroline-κ^2^<i>N</i>,<i>N</i>)bis(pyridin-4-amine- κ<i>N</i>^1^)ruthenium(II) bis(hexafluoridophosphate)
C34H28N8Ru2,2(F6P)
Acta Crystallographica Section E (2013) 69, 2 m75-m76
a=13.0943(3)Å b=14.5730(3)Å c=19.9366(5)Å
α=90° β=90° γ=90°
<i>cis</i>-Bis(2,2-bipyridine-κ^2^<i>N</i>,<i>N</i>')bis(pyridin-4-amine- κ<i>N</i>^1^)ruthenium(II) bis(hexafluoridophosphate) acetonitrile monosolvate
C30H28N8Ru2,2(F6P),C2H3N
Acta Crystallographica Section E (2013) 69, 2 m77-m78
a=10.8290(3)Å b=11.8890(3)Å c=16.1020(4)Å
α=104.0730(10)° β=99.114(2)° γ=107.761(2)°
<i>fac</i>-[1,2-Bis(pyridin-4-yl)ethane-κ<i>N</i>]tricarbonyl(1,10-phenanthroline-κ^2^<i>N</i>,<i>N</i>)rhenium(I) hexafluoridophosphate acetonitrile monosolvate
C27H20N4O3Re,PF6,C2H3N
Acta Crystallographica Section E (2014) 70, 7 m278-m279
a=10.5992(2)Å b=16.1201(3)Å c=17.3449(2)Å
α=90° β=100.8790(10)° γ=90°
2,4,6-trinitrophenyl 3-methylbenzoate
C14H9N3O8
Acta Crystallographica Section E (2012) 68, 7 o2187
a=7.49470(10)Å b=8.4366(2)Å c=23.8574(6)Å
α=90.00° β=99.3650(10)° γ=90.00°
3,5-Bis(benzyloxy)benzoic acid
C21H18O4
Acta Crystallographica Section E (2012) 68, 11 o3247-o3248
a=5.2801(2)Å b=11.6830(5)Å c=14.4803(7)Å
α=83.303(2)° β=80.775(2)° γ=79.0310(10)°
2,4,6-Trinitrophenyl 4-methylbenzoate
C14H9N3O8
Acta Crystallographica Section E (2012) 68, 11 o3107
a=7.6126(2)Å b=8.2124(2)Å c=23.9893(7)Å
α=90.00° β=94.4480(10)° γ=90.00°
5-chloroquinolin-8-yl furan-2-carboxylate
C14H8ClNO3
Acta Crystallographica Section E (2013) 69, 4 o501
a=4.07140(10)Å b=23.7463(7)Å c=12.7698(4)Å
α=90.00° β=102.1130(10)° γ=90.00°
2,4,6-trinitrophenyl 4-chlorobenzoate
C13H6ClN3O8
Acta Crystallographica Section E (2013) 69, 4 o570
a=9.3526(3)Å b=11.4793(3)Å c=13.6089(4)Å
α=90.00° β=93.612(2)° γ=90.00°
3-Diphenylaminoisobenzofuran-1(3H)-one
C20H15NO2
Acta Crystallographica Section E (2014) 70, 4 o490
a=19.1440(13)Å b=8.9363(6)Å c=9.1111(3)Å
α=90.00° β=90.00° γ=90.00°
2-[1'-(Benzyloxy)spiro[indane-1,2'-pyrrolidine]-5'-yl]acetonitrile
C21H22N2O
Acta Crystallographica Section E (2013) 69, 8 o1192-o1193
a=9.1688(4)Å b=10.0800(4)Å c=11.4141(6)Å
α=98.826(2)° β=108.777(2)° γ=110.403(4)°
4-Formyl-2-nitrophenyl 4-bromobenzoate
C14H8BrNO5
Acta Crystallographica Section E (2013) 69, 5 o793
a=6.5308(2)Å b=8.2253(2)Å c=25.6860(8)Å
α=90.00° β=103.1910(9)° γ=90.00°
2,4,6-trinitrophenyl 3-chlorobenzoate
C13H6ClN3O8
Acta Crystallographica Section E (2013) 69, 6 o966
a=11.0633(4)Å b=9.6560(4)Å c=14.0251(6)Å
α=90.00° β=94.009(2)° γ=90.00°
2,2'-(Carbonothioyldisulfanediyl)bis(2-methylpropanoic acid)
C9H14O4S3
Acta Crystallographica Section E (2013) 69, 5 o774
a=10.4044(2)Å b=10.4947(2)Å c=13.7744(3)Å
α=90.00° β=117.3630(10)° γ=90.00°
(+-)-3-(5-Amino-3-methyl-1-phenyl-1<i>H</i>-pyrazol-4-yl)-2-benzofuran-1(3<i>H</i>)-one
C18H15N3O2
Acta Crystallographica Section E (2013) 69, 7 o1181-o1182
a=10.0451(2)Å b=15.0631(5)Å c=12.2008(4)Å
α=90.00° β=123.257(2)° γ=90.00°
4-Formyl-2-nitrophenyl 2-chlorobenzoate
C14H8ClNO5
Acta Crystallographica Section E (2013) 69, 12 o1806
a=16.2367(7)Å b=7.1047(2)Å c=11.4018(3)Å
α=90° β=90° γ=90°
M-nitroaniline
C6H6N2O2
Chemistry of Materials (2000) 12, 11 3342-3346
a=18.905(4)Å b=6.484(1)Å c=5.016(1)Å
α=90.00° β=90.00° γ=90.00°
Estra-1,3,5(10)-triene-3,17-diol(17?)-17-pentanoate
C23H32O3
Crystal Growth & Design (2014) 14, 11 5700
a=7.3706(2)Å b=19.8583(5)Å c=13.9888(3)Å
α=90° β=90.619(2)° γ=90°
Estra-1,3,5(10)-triene-3,17-diol(17?)-17-pentanoate
C23H32O3
Crystal Growth & Design (2014) 14, 11 5700
a=7.5539(12)Å b=18.667(3)Å c=14.092(2)Å
α=90° β=90.402(8)° γ=90°
Cocrystal 5FC succinic acid
C4H4FN3O,0.5(C4H6O4)
Crystal Growth & Design (2014) 14, 9 4383
a=4.9209(3)Å b=8.6115(5)Å c=9.4689(6)Å
α=72.466(3)° β=75.129(3)° γ=89.747(3)°
Cocrystal 5FC adipic acid
C4H4FN3O,0.5(C6H10O4)
Crystal Growth & Design (2014) 14, 9 4383
a=5.2742(5)Å b=6.6650(7)Å c=12.8441(13)Å
α=86.411(6)° β=80.757(6)° γ=71.970(6)°
Cocrystal 5FC tereftalic acid
C4H4FN3O,0.5(C8H6O4)
Crystal Growth & Design (2014) 14, 9 4383
a=3.6265(3)Å b=9.5274(8)Å c=13.7902(12)Å
α=107.812(5)° β=92.036(4)° γ=96.844(4)°
C4H4FN3O,C4H6O5
C4H4FN3O,C4H6O5
Crystal Growth & Design (2014) 14, 9 4383
a=20.8980(4)Å b=14.8590(9)Å c=7.2440(11)Å
α=90° β=107.178(3)° γ=90°
Co-crystal of 5FC with benzoic acid
C11H10FN3O3
Crystal Growth & Design (2014) 14, 9 4383
a=9.0565(2)Å b=5.4318(2)Å c=22.8887(8)Å
α=90° β=92.8700(10)° γ=90°
C4H4FN3O,C4H3FN2O2
C4H4FN3O,C4H3FN2O2
Crystal Growth & Design (2014) 14, 9 4383
a=15.0176(3)Å b=3.56040(10)Å c=27.3113(4)Å
α=90° β=138.2820(10)° γ=90°
C12H16La2O14
C12H16La2O14
Crystal Growth & Design (2015) 15, 6 3015
a=7.976(8)Å b=12.006(14)Å c=12.284(10)Å
α=112.01(2)° β=90.05(3)° γ=100.58(5)°
C12H12La2O14
C12H12La2O14
Crystal Growth & Design (2015) 15, 6 3015
a=7.979(2)Å b=12.095(3)Å c=12.297(4)Å
α=111.681(11)° β=89.932(16)° γ=100.158(12)°
C12H12Nd2O14
C12H12Nd2O14
Crystal Growth & Design (2015) 15, 6 3015
a=7.8354(7)Å b=12.0496(16)Å c=12.2524(16)Å
α=112.015(5)° β=89.967(7)° γ=99.921(7)°
C12H16Gd2O14
C12H16Gd2O14
Crystal Growth & Design (2015) 15, 6 3015
a=7.7050(3)Å b=11.9893(7)Å c=12.1828(6)Å
α=112.143(2)° β=89.979(3)° γ=99.580(3)°
C12H18La2O15,2(H2O)
C12H18La2O15,2(H2O)
Crystal Growth & Design (2015) 15, 6 3015
a=10.2108(5)Å b=13.7312(7)Å c=14.7406(9)Å
α=90° β=90° γ=90°
C12H14O14Pr2
C12H14O14Pr2
Crystal Growth & Design (2015) 15, 6 3015
a=7.877(10)Å b=12.06(3)Å c=12.275(13)Å
α=112.12(4)° β=89.98(3)° γ=99.95(5)°
C33H33Cl3NP2Ru
C33H33Cl3NP2Ru
Inorganic Chemistry (2009) 48, 11 4692-4700
a=32.194(3)Å b=11.0531(9)Å c=35.705(3)Å
α=90° β=103.259(6)° γ=90°
C77.55H73.6Cl7.4N4Ni0.5O1.25P4Ru2
C77.55H73.6Cl7.4N4Ni0.5O1.25P4Ru2
Inorganic Chemistry (2009) 48, 11 4692-4700
a=13.9381(5)Å b=16.7433(6)Å c=19.91612(8)Å
α=105.726(2)° β=94.509(2)° γ=109.108(2)°
C14H23N4O7P2SSn,2(H2O),Cl
C14H23N4O7P2SSn,2(H2O),Cl
Inorganic Chemistry (2004) 43, 1957-1963
a=22.2209(4)Å b=8.8241(2)Å c=24.1119(6)Å
α=90.00° β=90.00° γ=90.00°
C13H12N4S
C13H12N4S
Inorganic Chemistry (2003) 42, 2584-2595
a=12.3340(2)Å b=11.6570(2)Å c=17.3750(4)Å
α=90.00° β=90.6540(10)° γ=90.00°
C64H62Cl4N8O2Pb3S2
C64H62Cl4N8O2Pb3S2
Inorganic Chemistry (2003) 42, 2584-2595
a=9.8300(5)Å b=11.8780(6)Å c=14.8020(8)Å
α=77.330(2)° β=85.924(2)° γ=73.693(2)°
C21H21Cl2N3PbS
C21H21Cl2N3PbS
Inorganic Chemistry (2003) 42, 2584-2595
a=8.5712(2)Å b=9.1760(2)Å c=14.1713(3)Å
α=90.6640(10)° β=94.6720(10)° γ=92.4770(10)°
C19H17ClN4PbS
C19H17ClN4PbS
Inorganic Chemistry (2003) 42, 2584-2595
a=13.3359(3)Å b=11.1170(3)Å c=13.5689(2)Å
α=90.00° β=93.600(2)° γ=90.00°
C32H32Cl4N4OPb2S
C32H32Cl4N4OPb2S
Inorganic Chemistry (2003) 42, 2584-2595
a=9.907(2)Å b=12.604(3)Å c=15.834(4)Å
α=109.016(4)° β=92.413(4)° γ=103.377(4)°
C20H19ClN4PbS
C20H19ClN4PbS
Inorganic Chemistry (2003) 42, 2584-2595
a=9.5816(17)Å b=10.0802(18)Å c=12.170(2)Å
α=95.587(3)° β=104.252(3)° γ=114.979(2)°
C14H14ClN3OPb0.5S
C14H14ClN3OPb0.5S
Inorganic Chemistry (2003) 42, 2584-2595
a=13.817(3)Å b=8.884(2)Å c=12.906(3)Å
α=90.00° β=94.019(5)° γ=90.00°
C12H16N4O2S
C12H16N4O2S
Inorganic Chemistry (2002) 41, 1550-1557
a=23.950(7)Å b=8.6790(10)Å c=13.778(3)Å
α=90.00° β=109.43(2)° γ=90.00°
C14H26N6O5S4Zn
C14H26N6O5S4Zn
Inorganic Chemistry (2002) 41, 1550-1557
a=10.7100(3)Å b=18.8440(6)Å c=12.1070(4)Å
α=90.00° β=97.485(3)° γ=90.00°
C16H30N6O5S4Zn
C16H30N6O5S4Zn
Inorganic Chemistry (2002) 41, 1550-1557
a=15.266(9)Å b=20.072(5)Å c=8.2770(10)Å
α=90.00° β=100.17(3)° γ=90.00°
C26H36N8O5S3Zn
C26H36N8O5S3Zn
Inorganic Chemistry (2002) 41, 1550-1557
a=12.781(3)Å b=12.311(3)Å c=21.147(3)Å
α=90.00° β=92.00(2)° γ=90.00°
Diethylcarbamazine citrate
C10H22N3O,C6H7O7
Crystal Growth & Design (2010) 10, 7 3094
a=13.8050(3)Å b=10.2581(2)Å c=13.9890(3)Å
α=90.00° β=93.689(2)° γ=90.00°
Diethylcarbamazine citrate
C6H7O7,C10H22N3O
Crystal Growth & Design (2010) 10, 7 3094
a=13.915(2)Å b=10.096(2)Å c=14.089(3)Å
α=90.0000° β=103.56(1)° γ=90.0000°
Diethylcarbamazine citrate
C10H22N3O,C6H7O7
Crystal Growth & Design (2010) 10, 7 3094
a=27.4386(7)Å b=10.1644(2)Å c=14.0536(3)Å
α=90.00° β=95.033(1)° γ=90.00°
Diethylcarbamazine citrate
C10H22N3O,C6H7O7
Crystal Growth & Design (2010) 10, 7 3094
a=13.656(5)Å b=10.259(5)Å c=13.902(6)Å
α=90.140(3)° β=95.389(3)° γ=92.677(3)°
Lamivudine double strand
C75H114Cl2N24O37S8
Crystal Growth & Design (2010) 10, 2 676
a=14.22190(20)Å b=25.60790(29)Å c=15.17540(20)Å
α=90.00° β=117.4652(5)° γ=90.00°
Didanosine
C10H12N4O3,0.125H2O
Crystal Growth & Design (2010) 10, 4 1885
a=7.277(1)Å b=10.052(2)Å c=14.476(3)Å
α=90.000° β=93.71(1)° γ=90.000°
Hexagram-Type Topology Lamivudine Duplex
3(C8H11N3O3S),2(H2O)
Crystal Growth & Design (2012) 12, 10 5138
a=14.550(1)Å b=14.550(1)Å c=29.538(3)Å
α=90.00° β=90.00° γ=120.00°
Lamivudine hemihydrochloride hemihydrate
C8H12N3O3S,C8H11N3O3S,H2O,Cl
Crystal Growth & Design (2012) 12, 10 5138
a=6.972(5)Å b=12.167(7)Å c=13.867(8)Å
α=100.52(3)° β=93.15(4)° γ=91.43(4)°
4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-(1H)-pyrimidin-2-one maleate
C8H12N3O3S,C4H3O4
Crystal Growth & Design (2009) 9, 12 5283
a=5.4584(3)Å b=12.8761(8)Å c=21.8161(13)Å
α=90.00° β=90.00° γ=90.00°
4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-(1H)-pyrimidin-2-one maleate
C8H12N3O3S,C4H3O4
Crystal Growth & Design (2009) 9, 12 5283
a=5.4130(1)Å b=12.7870(4)Å c=21.6501(7)Å
α=90.00° β=90.00° γ=90.00°
Chlortalidone Form I
C14H11ClN2O4S
Crystal Growth & Design (2009) 9, 7 3235
a=6.2270(2)Å b=8.3870(3)Å c=14.3640(4)Å
α=92.141(2)° β=101.050(2)° γ=107.024(2)°
Chlortalidone Form III
C14H11ClN2O4S
Crystal Growth & Design (2009) 9, 7 3235
a=7.9957(2)Å b=8.1467(2)Å c=11.4761(3)Å
α=80.448(2)° β=79.277(2)° γ=86.106(2)°
Maleate of 5-FC
C8H8FN3O5
Crystal Growth & Design (2013) 13, 10 4315
a=9.3450(5)Å b=11.8620(6)Å c=18.9540(8)Å
α=90° β=113.573(3)° γ=90°
Fumarate monohydrate of 5-FC
C6H8F1N3O4
Crystal Growth & Design (2013) 13, 10 4315
a=3.550(5)Å b=9.093(5)Å c=24.527(5)Å
α=90.000(5)° β=91.737(5)° γ=90.000(5)°